The research, conducted by Seong-Uk Baek and Jin-Ha Yoon of Yonsei University College of Medicine, drew on the Korean Longitudinal Study of Ageing, one of the most comprehensive national aging cohorts in Asia. The team followed 6,033 participants aged 45 and older, tracking their functional status across repeated survey waves between 2006 and 2014 and then linking those patterns to mortality records extending all the way to 2024. That eighteen-year observational window is unusually long for this kind of analysis, and it allowed the investigators to ask a question that single snapshots of disability cannot answer: does the trajectory of functional decline matter more than any single measurement of it?

To answer that question, the researchers employed a statistical technique known as group-based trajectory modeling, a form of latent class growth analysis that sorts individuals into distinct patterns of change over time rather than treating functional status as a fixed characteristic. Instead of asking whether someone had an IADL limitation at one point, the method asks how that limitation evolved across years of repeated assessments. The modeling revealed two clearly separable paths. The overwhelming majority of participants, 5,757 people or 95.4 percent of the sample, followed a stable low trajectory, maintaining essentially intact functional independence throughout the observation period. A smaller group of 276 people, 4.6 percent of the cohort, followed an increasing trajectory, in which IADL limitations accumulated progressively over the years.

When the researchers linked these trajectories to mortality outcomes using Cox proportional hazards regression, the contrast was stark. Members of the increasing-limitation group had an adjusted hazard ratio of 2.13 for all-cause mortality, with a 95 percent confidence interval of 1.79 to 2.52, meaning that after accounting for other measured factors, their risk of dying during follow-up was roughly twice that of people whose functional abilities remained stable. The adjustment for confounders is critical here, because functional decline rarely occurs in isolation; it tends to accompany chronic disease, advancing age, and socioeconomic disadvantage, all of which independently predict mortality. The fact that the association survived statistical adjustment strengthens the case that the trajectory of IADL limitation itself carries prognostic information.

But the most intriguing part of the study concerned mechanism. Why would losing the ability to shop, cook, or manage finances shorten life? One plausible answer lies in the psychological fallout of that loss. Functional decline erodes autonomy, shrinks social participation, and can produce a profound sense of lost self-efficacy, and each of these experiences is closely tied to depressive symptoms in older adults. Depression, in turn, is well documented as a predictor of mortality, through behavioral pathways such as reduced physical activity, poorer medication adherence, and worse diet, and through biological pathways including dysregulation of the hypothalamic-pituitary-adrenal axis and chronic low-grade inflammation. The Korean team hypothesized that depressive symptoms might act as a mediator—a statistical and biological waypoint through which functional decline exerts part of its lethal effect.

To measure depressive symptoms, the study used the ten-item version of the Center for Epidemiologic Studies-Depression Scale, a widely validated screening instrument that asks respondents about mood, energy, sleep, and feelings of worthlessness over the preceding week. Functional status was assessed with the Korean Instrumental Activities of Daily Living scale, a nationally validated measure covering domains such as telephone use, shopping, food preparation, housekeeping, laundry, transportation, medication management, and handling finances. The researchers then applied formal causal mediation analysis, using reproducible computational tools designed to decompose a total effect into its direct and indirect components, a methodologically rigorous approach that goes well beyond simple correlation.

The mediation results were striking. Depressive symptoms partially explained the link between the increasing IADL limitation trajectory and mortality, with an adjusted indirect hazard ratio of 1.09 and a 95 percent confidence interval of 1.05 to 1.15. The proportion of the total association mediated by depressive symptoms was estimated at 16.0 percent, with a confidence interval spanning 9.7 to 23.8 percent. In plain terms, roughly one in six of the excess deaths associated with worsening functional decline could be statistically attributed to the depression that accompanied that decline. The remaining 84 percent of the effect presumably reflects other mechanisms—underlying disease severity, cognitive deterioration, nutritional deterioration, reduced healthcare access, and the direct physiological consequences of frailty—since IADL ability is closely intertwined with brain health, including amyloid burden and frontal white matter integrity in neurodegenerative disease.

The findings fit into a growing body of international evidence. Previous studies have shown that IADL impairment predicts mortality in heart failure patients, that functional disability and depressive symptoms reinforce each other in a vicious cycle among older adults, and that depression independently elevates all-cause and cause-specific mortality across multiple populations. What distinguishes the new study is its longitudinal mediation design: rather than measuring disability, mood, and death at a single time point, it traced the developmental course of disability over eight years and then followed survival for another decade. That architecture makes the temporal ordering of the pathway—declining function, rising depressive symptoms, earlier death—considerably more credible than cross-sectional designs allow.

The public health implications are significant, particularly for rapidly aging societies like South Korea, where the proportion of older adults is among the highest in the world. If roughly one-sixth of the mortality risk attached to functional decline operates through depression, then mental health screening and treatment could become a concrete intervention target for a population that is often identified only after disability has already advanced. The authors’ analysis suggests that clinicians and caregivers should not view an emerging IADL limitation merely as a functional problem to be managed with assistive services, but as a psychological warning sign that warrants parallel attention to mood. Screening for depressive symptoms at the first sign of difficulty with shopping, finances, or medication management might interrupt the pathway before it compounds.

Several caveats deserve mention. The study population was Korean, and cultural factors surrounding family caregiving, social participation, and the expression of depressive distress may shape how strongly the mediation pathway operates elsewhere. Self-reported IADL and depression measures, while validated, are subject to reporting bias, and residual confounding by unmeasured health conditions can never be fully excluded in observational research. The mediation framework itself rests on assumptions about the absence of unmeasured confounding of both the disability-depression and depression-mortality relationships. Still, the size of the cohort, the length of follow-up, the use of trajectory modeling rather than static snapshots, and the formal mediation methodology together make this one of the more rigorous examinations to date of how daily function, mood, and mortality interconnect. For a world where hundreds of millions of people will live into old age, the message is sobering but actionable: protecting the small, practical abilities that sustain independence may protect not only quality of life but life itself, and tending to mental health along the way could blunt a measurable fraction of the risk.

Subject of Research: The mediating role of depressive symptoms in the link between trajectories of instrumental activities of daily living and all-cause mortality in middle-aged and older adults

Article Title: Mediating role of depressive symptoms in the association between trajectories of instrumental activities of daily living and all-cause mortality in middle-aged or older adults: a cohort study in South Korea

Article References: Baek, S.-U., & Yoon, J.-H. (2026). Mediating role of depressive symptoms in the association between trajectories of instrumental activities of daily living and all-cause mortality in middle-aged or older adults: a cohort study in South Korea. GeroScience. https://doi.org/10.1007/s11357-026-02536-w

Image Credits: AI Generated

DOI: 10.1007/s11357-026-02536-w

Keywords: instrumental activities of daily living, depressive symptoms, all-cause mortality, aging, cohort study, South Korea, Korean Longitudinal Study of Ageing, functional decline, mediation analysis, geroscience, older adults, mental health